Adebrelimab

Tax included
Adebrelimab (SHR-1316) is a humanized IgG4 monoclonal PD-L1 (PD-1/PD-L1) antibody. Adebrelimab has promising antitumor activity in solid tumors including extensive-stage small-cell lung cancer (SCLC).
MedChemExpress 
HY-P99422

Data sheet

Size
Multiple sizes
Reactivity
PD-1/PD-L1; Apoptosis
Application
Cancer-programmed cell death
CAS
2247114-85-6